Works by van Erp, N. P.
Results: 8
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 258, doi. 10.1111/dom.12605
- By:
- Publication type:
- Article
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 4, p. 353, doi. 10.1007/s00280-023-04615-7
- By:
- Publication type:
- Article
Myelosuppression by sunitinib is flt-3 genotype dependent.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 4, p. 465, doi. 10.1007/s00228-017-2394-0
- By:
- Publication type:
- Article
Unintentional combining enzalutamide with a moderate CYP2C8 inhibitor in a patient with metastatic castration-resistant prostate cancer: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A pharmacological rationale for improved everolimus dosing in oncology and transplant patients.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1575, doi. 10.1111/bcp.13591
- By:
- Publication type:
- Article